Default: Nature Reviews Rheumatology

ISSN: 1759-4790

Journal Home

Journal Guideline

Nature Reviews Rheumatology Q1 Unclaimed

Nature Publishing Group United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Nature Reviews Rheumatology is a journal indexed in SJR in Rheumatology with an H index of 137. It has an SJR impact factor of 2,683 and it has a best quartile of Q1. It has an SJR impact factor of 2,683.

Nature Reviews Rheumatology focuses its scope in these topics and keywords: developed, linked, ra, effectiveness, effective, distinct, disease, disappointmentsclassification, diabetes, decreased, ...

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Scopus WOS
Categories: Rheumatology (Q1)
Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Nature Reviews Rheumatology

2,683

SJR Impact factor

137

H Index

195

Total Docs (Last Year)

613

Total Docs (3 years)

7286

Total Refs

2972

Total Cites (3 years)

381

Citable Docs (3 years)

4,13

Cites/Doc (2 years)

37,36

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


developed, linked, ra, effectiveness, effective, distinct, disease, disappointmentsclassification, diabetes, decreased, exacerbates, fibroblastlike, fibrosisadhesivehydrogel, fmf, gout, health, hopes, il, imprinted, inflammationminimal, data, damages, aggressorsbone, osteoarthritis, ankylosing, arthritisgalectin, block, blockade, bone, cardiovascular, careanakinra, cartilage, cartilagecomparative, classification, composite, controlled, criteria, damaged,



Best articles by citations

Fire and ice: syndecan-3 in inflammation

View more

Optical molecular imaging to detect early endothelial activation: a promising novel modality for RA?

View more

Genetic architectures of seropositive and seronegative rheumatic diseases

View more

Evidence of gut-driven inflammation in new JIA

View more

Could early biologics prevent disease?

View more

Chondrocyte protection - SIRTified?

View more

Optimizing withdrawal of therapy to sustain remission

View more

Could IL-23 go solo as a therapeutic target for psoriasis?

View more

Management of hereditary recurrent fevers - SHARE experience

View more

IL-20 blockade to block bone loss?

View more

Safety of biologic therapy in rheumatoid arthritis

View more

A mechanism of B cell hyperactivity in SLE

View more
SHOW MORE ARTICLES

Another cog in the mechanism of methotrexate

View more

Tipping the balance towards resolution

View more

How macrophages mediate inflammatory pain via ATP signaling

View more

Anti-inflammatory hope for AIN457

View more

Coeliac disease and rheumatoid arthritis: similar mechanisms, different antigens

View more

Do autoantibodies to C3 exacerbate autoimmunity in SLE?

View more

Dermal white adipose tissue implicated in SSc pathogenesis

View more

siRNA-based therapeutic approaches for rheumatic diseases

View more

Species-specific TLR signalling - insight into human disease

View more

Progress in imaging in rheumatology

View more

A nose for cartilage repair

View more

Management of psoriatic arthritis from the view of the dermatologist

View more

FAQS